Evidence map›Paper›PMID 26938874›Full record

ArticlePloS one2016

Role of CTCF in Regulating SLC45A3-ELK4 Chimeric RNA.

Fujun Qin, Yansu Song, Yanmei Zhang, Loryn Facemire, Henry Frierson, Hui Li

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. OncogenicMedComm · 2024
    Article
  4. Article
  5. Article
  6. Chimeric RNAiScience · 2023
    Article
  7. Review
  8. The Fusion ofInternational journal of molecular sciences · 2021
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Chimeric RNAs and their implications in cancer.Current opinion in genetics & development · 2018
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Fujun QinDepartment of Pathology, School of Medicine, University of Virginia, Charlottesville, Virginia, United States of America.
Yansu SongDepartment of Pathology, School of Medicine, University of Virginia, Charlottesville, Virginia, United States of America.
Yanmei ZhangZhejiang Academy of Medical Sciences, Hangzhou, Zhejiang, China.
Loryn FacemireDepartment of Pathology, School of Medicine, University of Virginia, Charlottesville, Virginia, United States of America.
Henry FriersonDepartment of Pathology, School of Medicine, University of Virginia, Charlottesville, Virginia, United States of America.
Hui LiDepartment of Pathology, School of Medicine, University of Virginia, Charlottesville, Virginia, United States of America.
University of Virginia · USZhejiang Academy of Medical Sciences · CN

Funding

Women's Oncology Program - WONP30CA044579 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Thomas P. Loughran · 1987 to 2026
$72.1M
Induction of Gene Fusions by Pre-Existing Chimeric TranscriptsR01CA190713 · NCI · UNIVERSITY OF VIRGINIA · PI LI, HUI · 2014 to 2018
$1.8M
NCI NIH HHS P30 CA044579NCI NIH HHS R01 CA190713
6 · The paper itself

Abstract

The chimeric RNA, SLC45A3-ELK4, was found to be a product of cis-splicing between the two adjacent genes (cis-SAGe). Despite the biological and clinical significance of SLC45A3-ELK4, its generating mechanism has not been elucidated. It was shown in one cell line that the binding of transcription factor CTCF to the insulators located at or near the gene boundaries, inversely correlates with the level of the chimera. To investigate the mechanism of such cis-SAGe events, we sequenced potential regions that may play a role in such transcriptional read-through. We could not detect mutations at the transcription termination site, insulator sites, splicing sites, or within CTCF itself in LNCaP cells, thus suggesting a "soft-wired" mechanism in regulating the cis-SAGe event. To investigate the role CTCF plays in regulating the chimeric RNA expression, we compared the levels of CTCF binding to the insulators in different cell lines, as well as clinical samples. Surprisingly, we did not find an inverse correlation between CTCF level, or its bindings to the insulators and SLC45A3-ELK4 expression among different samples. However, in three prostate cancer cell lines, different environmental factors can cause the expression levels of the chimeric RNA to change, and these changes do inversely correlate with CTCF level, and/or its bindings to the insulators. We thus conclude that CTCF and its bindings to the insulators are not the primary reasons for differential SLC45A3-ELK4 expression in different cell lines, or clinical cases. However, they are the likely mechanism for the same cells to respond to different environmental cues, in order to regulate the expression of SLC45A3-ELK4 chimeric RNA. This response to different environmental cues is not general to other cis-SAGe events, as we only found one out of 16 newly identified chimeric RNAs showing a pattern similar to SLC45A3-ELK4.

Indexed as

Gene Expression Regulation, NeoplasticBase SequenceBinding SitesCCCTC-Binding FactorCell Line, TumorChromatin Immunoprecipitationets-Domain Protein Elk-4HEK293 CellsHumansMaleMembrane Transport ProteinsMolecular Sequence DataMonosaccharide Transport ProteinsMutationPoint MutationProstatic NeoplasmsCCCTC-Binding FactorCTCF protein, humanELK4 protein, humanets-Domain Protein Elk-4Membrane Transport ProteinsMonosaccharide Transport ProteinsRepressor ProteinsRNASLC45a3 protein, human

Identifiers

PMID26938874
PMCPMC4777538
OpenAlexW2291554482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.